Misty Gilley
Family · Elizabethtown, KYNPI 1891141529
Payments from drug & device makers
Across 313 payments — averaging $15.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$993
- AbbVie$594
- Bayer$400
- Amgen$365
- Pfizer$360
- Biohaven Pharmaceuticals, Inc.$339
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,906100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 56 | $993 |
| AbbVie | 41 | $594 |
| Bayer | 26 | $400 |
| Amgen | 25 | $365 |
| Pfizer | 30 | $360 |
| Biohaven Pharmaceuticals, Inc. | 17 | $339 |
| Lilly USA, LLC | 18 | $257 |
| Biohaven Pharmaceutical Holding Company Ltd. | 19 | $256 |
| Boehringer Ingelheim | 11 | $185 |
| AstraZeneca | 10 | $142 |
| Novartis | 8 | $121 |
| Sunovion Pharmaceuticals Inc. | 8 | $102 |
| GSK | 7 | $91 |
| Johnson & Johnson | 3 | $91 |
| Sumitomo Pharma America, Inc. | 3 | $73 |
| Paratek Pharmaceuticals, Inc. | 3 | $51 |
| Phathom Pharmaceuticals, Inc. | 3 | $49 |
| Otsuka America Pharmaceutical, Inc. | 3 | $49 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Radius Health, Inc. | 2 | $38 |
| Bone Support Inc. | 1 | $36 |
| Exact Sciences | 2 | $35 |
| Esperion Therapeutics, Inc. | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 2 | $30 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
| Supernus Pharmaceuticals, Inc. | 2 | $28 |
| Alkermes, Inc. | 1 | $20 |
| Abbott | 1 | $20 |
| Merck | 1 | $17 |
| Lundbeck LLC | 1 | $17 |
| Astellas Pharma US Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wegovy$120
- NURTEC ODT$117
How this compares
$4,906 in reported general payments places this provider in the 90th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 64 | $71,892 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 100 | $71,037 |
| EliquisApixaban | 70 | $66,628 |
| OzempicSemaglutide | 44 | $62,264 |
| MounjaroTirzepatide | 37 | $54,200 |
| XareltoRivaroxaban | 49 | $35,180 |
| JardianceEmpagliflozin | 48 | $32,362 |
| Repatha SureclickEvolocumab | 53 | $28,559 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 27 | $26,741 |
| JanuviaSitagliptin Phosphate | 16 | $21,551 |
| Bydureon BciseExenatide Microspheres | 15 | $15,003 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 24 | $14,201 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 24 | $11,276 |
| JanumetSitagliptin Phos/Metformin Hcl | 21 | $10,995 |
| NeuproRotigotine | 13 | $10,700 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $257 | $126,093101 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $91 | $82,313124 claims |
| PfizerEliquis | $360 | $66,62870 claims |
| Novo NordiskOzempic | $993 | $62,26444 claims |
| Johnson & JohnsonXarelto, Invokana | $91 | $41,96161 claims |
| Boehringer IngelheimJardiance, Tradjenta | $185 | $38,31160 claims |
| MerckJanuvia, Janumet | $17 | $32,54637 claims |
| AstraZenecaBreztri Aerosphere | $142 | $14,20124 claims |
| Astellas Pharma US IncMyrbetriq | $13 | $5,44313 claims |
| AbbVieSynthroid | $594 | $4,35691 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,374 family providers in Kentucky.
Other family in Elizabethtown
- Ashley SnellenElizabethtown$190K
- Gwendolynn ThomasElizabethtown$12K
- Bonnie HillLouisa$372K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.